Results 211 to 220 of about 123,724 (326)

CAR-engineered lymphocyte persistence is governed by a FAS ligand-FAS autoregulatory circuit. [PDF]

Nat Cancer
Yi F, Cohen T, Zimmerman N, Dündar F, Zumbo P, Eltilib R, Brophy EJ, Arkin H, Feucht J, Gormally MV, Hackett CS, Kropp KN, Etxeberria I, Chandran SS, Zhao Z, Cai W, Daniyan AF, Park JH, Lareau CA, Hsu KC, Sadelain M, Betel D, Klebanoff CA.   +22 more
europepmc   +1 more source

Organ microenvironment plays significant roles through Fas ligand in vaccine‐induced CD4⁺ T cell dependent suppression of tumor growth at the orthotopic site

, 2010
Daisuke Sugiura, Kaori Denda‐Nagai, Kazuyoshi Takeda, Tatsuro Irimura   +3 more
openalex   +2 more sources

Protection of islet allografts transplanted together with Fas ligand expressing testicular allografts [PDF]

, 1998
Y. Takeda, Mitsukazu Gotoh, Keizo Dono, Michi Nishihara, Tadeusz Grochowiecki, Fumihiko Kimura, Takashi Yoshida, Y. Ohta, Hideo Ôta, Hiroki Ohzato, Koji Umeshita, Tsutomu Takeda, Nariaki Matsuura∥, Masato Sakon, Nobuhiko Kayagaki, Hideo Yagita∥, Ko Okumura, Masayuki Miyasaka, Morito Monden   +18 more
openalex   +1 more source

Autoimmunity and Periodontitis

Journal of Periodontal Research, EarlyView.
In a microbe‐driven inflammatory environment, peptidyl‐arginine deiminase (PAD) enzymes from neutrophils and Porphyromonas gingivalis citrullinate both microbial and self‐antigens. B cell presentation of citrullinated or self‐mimicking epitopes activates T cells that assist B cells in antibody isotype switching, affinity maturation, epitope spreading ...
Massimo Costalonga, Vivek Thumbigere‐Math, Mark C. Herzberg   +2 more
wiley   +1 more source

Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy. [PDF]

Nat Commun
Wamba BEN, Mondal T, Freenor V F, Shaheed M, Pang O, Bedinger D, Legembre P, Devel L, Bhatnagar S, Leiserowitz GS, Tushir-Singh J.   +10 more
europepmc   +1 more source

Flow cytometric phenotyping of diverse human cancer cell lines for immunological biomarkers expression [PDF]

The tumour microenvironment contains a variety of distinct factors that inhibit the immune system and can cause drug resistance. Some of these factors include the expression of cell surface markers which interact directly with immune cells.
Cross, Neil, Hudson, Katie, Jordan-mahy, Nicola, Leyland, Rebecca   +3 more
core  

CD36 and Its Role in Obesity

Obesity Reviews, EarlyView.
ABSTRACT Obesity is understood as a condition driven by interactions between genetics and environmental factors. The role of CD36 in the regulation of lipid metabolism and ectopic fat accumulation emerges as a key area of interest. This review presents CD36 not only as a crucial facilitator of fatty acid uptake but also as a regulator of how and where ...
Nahuel Garcia, Maiken Mellergaard, Carlos Salomon, Pilar Sepulveda, Peter Kristensen, Aase Handberg   +5 more
wiley   +1 more source

Strong activation of p53 by actinomycin D and nutlin-3a overcomes the resistance of cancer cells to the pro-apoptotic activity of the FAS ligand. [PDF]

Apoptosis
Łasut-Szyszka B, Gdowicz-Kłosok A, Krześniak M, Głowala-Kosińska M, Będzińska A, Rusin M.   +5 more
europepmc   +1 more source

Harnessing blue light photobiomodulation for cancer therapy: Evidence from a systematic review

Photochemistry and Photobiology, EarlyView.
Conventional treatments for various types of cancer are often associated with tumor recurrence and aggressiveness. Photobiomodulation with blue light (BL; 450–470 nm) emerges as a promising alternative with antitumor effects. This systematic review, with 37 in vitro and in vivo studies from 2002 to 2024, revealed that BL reduces cell viability ...
Bárbara Evelyn Santos de Lima, Rebeca Barros Nascimento, Ana Paula Mariano Santos Ginez, Maria Stella Moreira, Rebeca Boltes Cecatto, Rodrigo Labat Marcos, Maria Fernanda Setúbal Destro Rodrigues   +6 more
wiley   +1 more source

Prognostic Value of Fas/Fas Ligand Expression on Circulating Tumor Cells (CTCs) and Immune Cells in the Peripheral Blood of Patients with Metastatic Breast Cancer. [PDF]

Cancers (Basel)
Papadaki MA, Papadaki E, Chatziavraam S, Aggouraki D, Michaelidou K, Fotsitzoudis C, Vassilakopoulou M, Mavroudis D, Agelaki S.   +8 more
europepmc   +1 more source